This article appeared April 30, 2014, in the online edition of ADVANCE.
1. Diabetes Care; Position Statement; Standards of Medical Care in Diabetes- 2013; VA North Texas (January, 2013) by American Diabetes Association; doi: 10.2337/dc13-S011 vol. 36 no. Supplement 1 S11-S66; Retrieved online September 21, 2013 http://care.diabetesjournals.org/content/36/Supplement_1/S11.full
2. Gebel E., (May, 2010); The Other Diabetes: LADA, or Type 1.5; Latent autoimmune diabetes in adults is gradually being understood; Diabetesforecast : The healthy Living magazine by American Diabetes Association; retrieved online August 16, 2013 from http://forecast.diabetes.org/magazine/features/other-diabetes-lada-or-type-15
3. Gebel E., (May, 2010); Another Kind of Diabetes: MODY Often misdiagnosed, the disease is caused by a faulty gene; Diabetesforecast The healthy Living magazine by ADA: retrieved online August 16, 2013 from http://forecast.diabetes.org/magazine/features/another-kind-diabetes-mody
4. Mensing C., (2011); American Association of Diabetes Educators; The Art and Science of Diabetes Self Management: Education Desk Reference” 2nd edition; Page: 288Diabetes Care:
5. Diagnosis and Classification of Diabetes Mellitus (January, 2011) by American Diabetes Association; 34 (Suppl 1): S62-S69. doi: 10.2337/dc11-S062; retrieved online September 21, 2013 from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006051/
6. Garber A. J., et.al (May/June 2013); AACE/ADA Consensus Statement – American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement; Endocrine Practice Vol 19 (Suppl 2); Retrieved online October 27, 2013 from https://www.aace.com/files/algorithm-07-11-2013.pdf
7. Aron D, Douglass A et al (Update- August, 2010); VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus (version.4) with support from The Office of Quality and Performance, VA, Washington, DC & Quality Management Division, United States Army MEDCOM; Retrieved online September 27, 2013 from http://www.healthquality.va.
8. JNJ (October, 2013); U.S. FDA Approves INVOKANA™ (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes; Retrieved online October, 7, 2013 from http://www.jnj.com/news/all/us-fda-approves-invokana-canagliflozin-for-the-treatment-of-adults-with-type-2-diabetes
9. Henske J. M, Griffith M.L., Fowler M J; Clinical Diabetes (2009); by American Diabetes Association; Initiating and Titrating Insulin in Patients with Type 2 Diabetes; Retrieved online September 12, 2013 from http://clinical.diabetesjournals.org/content/27/2/72.full
